An Uncontrolled, Open-label, Exploratory Trial Investigating Temporal Changes in Microcirculatory Dysfunction in Patients with Takotsubo Syndrome Using Pressurewire X

未提供0 个研究点目标入组 12 人开始时间: 待定最近更新: 2024年4月2日

试验速览

暂无简介。

•This clinical trial sets two stages of selection criteria, primary registration and secondary registration, and targets patients who meet all the criteria at each stage. Primary registration is conducted for patients suspected of having Takotsubo syndrome. Secondary registration is conducted after catheter examination.
•Primary Registration:
•1, Adults aged 18 and over at the time of consent acquisition.
•2, Patients who have received sufficient explanation about participating in this trial, have a full understanding, and have obtained written consent by their own free will or that of a proxy.
•3, Patients who are hospitalized at Chiba University Hospital, or are scheduled to be hospitalized after a cardiac catheter examination.
•4, Patients suspected of having Takotsubo syndrome based on primary examinations (electrocardiogram, echocardiogram, blood tests, etc.).
•Secondary Registration:
•1, Patients diagnosed with Takotsubo syndrome as a result of cardiac catheter examination, and who can continue to measure IMR, CFR, and CS-Lac/Ao-Lac ratio.

•Patients conflicting with any of the following will not be included in this clinical trial:
•1, Patients from whom consent cannot be obtained, either from themselves or a proxy.
•2, Patients deemed unsuitable as subjects by the trial responsible (sub) physician.

microvascular resistance index by pressurewireX (Abbott)

时间窗: acute phase - after 3 months

Changes over time (acute phase - after 3 months)

发起方

未提供